These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7722489)
1. NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release. Nankai M; Fage D; Carter C J Neurochem; 1995 May; 64(5):2043-8. PubMed ID: 7722489 [TBL] [Abstract][Full Text] [Related]
2. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds. Nankai M; Klarica M; Fage D; Carter C Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463 [TBL] [Abstract][Full Text] [Related]
3. NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro. Nicolas C; Fage D; Carter C J Neurochem; 1994 May; 62(5):1835-9. PubMed ID: 7908945 [TBL] [Abstract][Full Text] [Related]
4. Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, gamma-aminobutyric acid, acetylcholine and spermidine release. Nankai M; Fage D; Carter C Eur J Pharmacol; 1995 Nov; 286(1):61-70. PubMed ID: 8566152 [TBL] [Abstract][Full Text] [Related]
5. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters. Nankai M; Klarica M; Fage D; Carter C Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166 [TBL] [Abstract][Full Text] [Related]
6. Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition. Fink K; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):312-9. PubMed ID: 8878061 [TBL] [Abstract][Full Text] [Related]
7. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669 [TBL] [Abstract][Full Text] [Related]
8. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. Carter CJ; Lloyd KG; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016 [TBL] [Abstract][Full Text] [Related]
9. Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation. Blanchet F; Gauchy C; Pérez S; Soubrié P; Glowinski J; Kemel ML Brain Res; 2000 Jan; 853(1):142-50. PubMed ID: 10627318 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro. Toner CC; Stamford JA Eur J Pharmacol; 1997 Dec; 340(2-3):133-43. PubMed ID: 9537807 [TBL] [Abstract][Full Text] [Related]
11. NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. Morari M; Sbrenna S; Marti M; Caliari F; Bianchi C; Beani L J Neurochem; 1998 Nov; 71(5):2006-17. PubMed ID: 9798925 [TBL] [Abstract][Full Text] [Related]
12. Role of arachidonic acid in the regulation of the NMDA-evoked release of acetylcholine in striatal compartments. Blanchet F; Gauchy C; Perez S; Glowinski J; Kemel ML Synapse; 1999 Feb; 31(2):140-50. PubMed ID: 10024011 [TBL] [Abstract][Full Text] [Related]
13. Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release. Sacaan AI; Johnson KM J Pharmacol Exp Ther; 1990 Dec; 255(3):1060-3. PubMed ID: 2148186 [TBL] [Abstract][Full Text] [Related]
14. Selective release of spermine and spermidine from the rat striatum by N-methyl-D-aspartate receptor activation in vivo. Fage D; Voltz C; Scatton B; Carter C J Neurochem; 1992 Jun; 58(6):2170-5. PubMed ID: 1533418 [TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists. Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA Brain Res; 1992 Mar; 574(1-2):42-8. PubMed ID: 1353403 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of N-methyl-D-aspartate-evoked [3H]noradrenaline release in adult rat spinal cord. Klarica M; Fage D; Carter C Eur J Pharmacol; 1996 Jul; 308(2):135-44. PubMed ID: 8840124 [TBL] [Abstract][Full Text] [Related]
17. Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of the NMDA receptor. Taylor CA; Tsai C; Lehmann J Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):552-5. PubMed ID: 2842697 [TBL] [Abstract][Full Text] [Related]
18. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. Brackley PT; Bell DR; Choi SK; Nakanishi K; Usherwood PN J Pharmacol Exp Ther; 1993 Sep; 266(3):1573-80. PubMed ID: 7690404 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices. Mayer A; Szasz BK; Kiss JP Neurochem Int; 2009 Nov; 55(6):383-8. PubMed ID: 19393275 [TBL] [Abstract][Full Text] [Related]
20. Ouabain releases striatal polyamines in vivo independently of N-methyl-D-aspartate receptor activation. Fage D; Voltz C; Carter C J Neurochem; 1993 Jul; 61(1):261-5. PubMed ID: 8515272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]